Playback speed
10 seconds
This video is featured in the 2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: MOTION Trial - Updated Efficacy & Safety of Vimseltinib in Patients With Tenosynovial Giant Cell Tumor
By
2024 ESMO Annual Meeting Insights Hub
FEATURING
Hans Gelderblom
By
2024 ESMO Annual Meeting Insights Hub
FEATURING
Hans Gelderblom
16 views
September 25, 2024
Login to view comments.
Click here to Login